Personalized Medical Care & Dedicated International Patient Concierge
Medical Guide
Focused and Radial Shockwave Therapy (ESWT) in Seoul
Learn how focused and radial shockwave therapy (ESWT) works, the honest evidence, US FDA facts, and recovery, from an orthopedic clinic in Seoul, Korea.
Schedule a ConsultationFocused and Radial Shockwave Therapy (ESWT) in Seoul
Medically reviewed by Dr. Heejun Kim, Board-Certified Orthopedic Surgeon, Chief Director, Nucellin Orthopedic Clinic
Extracorporeal shockwave therapy, usually shortened to ESWT, is one of the more widely used non-invasive options for stubborn tendon and heel pain. It is also frequently misunderstood, partly because the same word "shockwave" is used for several different technologies. This article explains what ESWT actually is, how focused and radial shockwaves differ, what the evidence supports, what the United States regulatory facts are, and what the recovery process typically looks like. It is written for international patients researching ESWT at Nucellin Orthopedic Clinic in Seoul who want a clear, honest picture rather than marketing language.
Here is the most important context first. In the United States, ESWT is FDA-approved for two specific musculoskeletal conditions in adults after conservative care has failed: chronic proximal plantar fasciitis (approved in 2000) and chronic lateral epicondylitis, or tennis elbow (approved in 2003). For most other musculoskeletal uses, ESWT is considered off-label. Care at Nucellin Orthopedic Clinic is delivered in the Republic of Korea under Korean medical regulation, not under U.S. regulation. ESWT is non-invasive and typically given as a course of sessions, but individual responses vary and no outcome is guaranteed.
What ESWT Actually Is
ESWT delivers acoustic pressure waves through the skin to a targeted area of tissue. The waves are generated by a device outside the body, which is what "extracorporeal" means, and are directed at a painful tendon, enthesis (where tendon meets bone), or soft-tissue structure. The goal is to stimulate the body's own response in that area rather than to cut, inject, or remove anything.
The exact biological mechanisms are still being studied, but the leading explanations involve mechanotransduction, the process by which cells sense and respond to mechanical force. Proposed effects include changes in local blood flow, stimulation of cellular signaling involved in repair, and modulation of pain signaling. It is honest to say that these mechanisms are plausible and supported by laboratory and clinical work, while also acknowledging that shockwave therapy is not a magic switch and that the size of any benefit differs from person to person.
At Nucellin Orthopedic Clinic, ESWT is delivered using the STORZ MEDICAL Ultra SD1, a system that provides both focused and radial shockwaves. Having both modes available in one device allows the treatment to be matched to the depth and type of the target problem, which is discussed below.
Focused Versus Radial Shockwaves
The word "shockwave" is used for two physically different technologies, and understanding the difference helps set realistic expectations.
Focused shockwaves are true shockwaves in the physical sense: high-energy acoustic pulses that can be concentrated at a specific depth beneath the skin. Because the energy converges at a focal point, focused shockwaves can reach deeper structures and deliver energy more precisely to a defined target, such as a deep tendon insertion. This is the same broad family of technology used in some other medical fields to concentrate acoustic energy.
Radial shockwaves, sometimes more accurately called radial pressure waves, are generated differently, often by a projectile mechanism inside a handpiece. Their energy is highest at the surface and spreads outward and dissipates with depth, so they tend to affect broader, more superficial areas. Radial waves are commonly used for larger or shallower regions of muscle and soft tissue.
Neither mode is universally "better." They are simply suited to different problems. A superficial, diffuse area of soft-tissue pain may respond well to radial treatment, while a deeper, well-localized tendon or enthesis problem may be better addressed with a focused approach. A dual-mode device such as the STORZ Ultra SD1 lets the physician select, or combine, the approach that fits the diagnosis. Which mode, if either, is appropriate for you is a clinical decision made after examination, not something that can be decided from a website.
What the Evidence Shows
The evidence for ESWT is strongest for the two conditions that led to U.S. FDA approval: chronic plantar fasciitis and chronic lateral epicondylitis, in adults who have already tried and failed conservative treatment for six months or more. For these indications there is randomized, sham-controlled trial data supporting a real, if variable, benefit over placebo.
Beyond those two, ESWT has been studied in a range of other conditions, including calcific tendinopathy of the shoulder, Achilles and patellar tendinopathy, and greater trochanteric pain, among others. For several of these, the published literature is encouraging, but the quality and consistency of studies vary, and in the United States these uses remain off-label. The honest summary is that ESWT may help selected patients with certain tendon and enthesis problems, that the evidence is stronger for some conditions than others, and that no result can be guaranteed for any individual.
It is also worth being clear about what ESWT is not. It is not a substitute for a correct diagnosis, and it does not "cure" a joint or "regrow" tissue on demand. It is one non-invasive tool that, in the right patient with the right problem, may support symptom improvement as part of a broader plan.
The US Regulatory Facts, Stated Plainly
Because regulatory precision matters, here are the facts as documented by the U.S. FDA. An extracorporeal shockwave system was originally approved in the United States on October 12, 2000, for treating chronic proximal plantar fasciitis that had failed to respond to conservative treatment, defined as heel pain persisting for six months or more. A supplement approved on March 14, 2003, expanded the indication to include chronic lateral epicondylitis (tennis elbow) that had failed to respond to conservative treatment for at least six months.
Two points follow from this. First, U.S. approval is tied to specific conditions and to patients who have already failed conservative care, not to shockwave therapy in general. Second, a device being approved or cleared in the United States is a statement about the U.S. regulatory pathway; it does not describe the treatment you would receive in Korea. At Nucellin Orthopedic Clinic, ESWT is provided under Korean medical regulation. When ESWT is used for conditions other than plantar fasciitis or tennis elbow, that use would be considered off-label from the U.S. perspective, and it is fair for patients to know this when weighing their options.
Who Might Be a Candidate
ESWT is not appropriate for everyone, and candidacy is decided by a physician after evaluation, never by a symptom checklist. A typical assessment includes a careful history, a physical examination, and appropriate imaging. Imaging such as X-ray or ultrasound is a diagnostic tool that helps identify and localize the problem; it is not itself a treatment.
A conservative-first approach is sensible and, for the FDA-approved indications, is actually part of the definition: ESWT is intended for patients whose symptoms have persisted despite conservative measures. Reasonable first steps for many tendon and heel problems include relative rest, activity modification, stretching and loading exercises, appropriate footwear or orthotics, and time. ESWT may be considered when these measures have not been enough and the clinical picture fits.
There are also situations where shockwave therapy is generally avoided or used with caution, and this is another reason the decision must be individualized with a qualified clinician who knows your full medical history. Pregnancy, certain bleeding disorders or anticoagulation, active infection or malignancy in the treatment area, and treatment directly over certain structures are examples of factors a physician will weigh.
What the Recovery Process Looks Like
One of the practical attractions of ESWT is that it is non-invasive and typically performed as an outpatient procedure. There are no incisions, and most patients return to their day with only simple aftercare.
A course usually involves several sessions spaced over a few weeks, rather than a single treatment, because the response tends to build gradually. The exact number of sessions, the energy settings, and the interval between them are individualized based on the diagnosis and how you respond, and should not be presented as a fixed formula that works identically for everyone. During the procedure, patients often feel a tapping or pulsing sensation and some discomfort at the treatment site; the intensity is generally adjustable, and your clinician will guide this.
Afterward, temporary soreness, redness, mild swelling, or bruising at the treated area can occur and usually settles within a short time. Your clinician will explain activity guidance for your specific case; for some tendon problems, a gradual return to loading exercises is encouraged rather than complete rest. Importantly, improvement is often not immediate. Many patients notice change over the weeks following a course rather than the same day, and some do not respond as hoped. Honest expectations are part of good care: ESWT aims to reduce pain and support function in appropriately selected patients, with results that vary.
Why Diagnosis Matters More Than the Device
It is tempting to focus on the machine, and a capable dual-mode system such as the STORZ Ultra SD1 does give a clinician useful options. But the device is only as good as the diagnosis that guides it. Two people with heel pain, or two people with elbow pain, may have quite different underlying problems, and shockwave therapy is not equally appropriate for all of them.
This is why a careful history, a hands-on examination, and appropriate imaging come before any recommendation. Localizing the true source of pain, confirming that the problem is one that plausibly responds to ESWT, and ruling out conditions that would call for a different approach all matter more than which mode a device offers. A clinician who takes the time to establish exactly what is causing your pain, and who is candid about what ESWT can and cannot do, is more valuable than one who applies the same treatment to everyone.
Cost and Insurance Context
This article does not discuss prices. It is useful to know, however, that in the United States elective and regenerative orthopedic treatments are frequently not covered by health insurance, and coverage for ESWT specifically varies by plan and indication. Coverage rules differ by country and by individual policy, so confirm the specifics with your own insurer and directly with the clinic. To ask about your own situation, you can visit the clinic website or the contact page.
About the Clinic and the Reviewing Physician
Nucellin Orthopedic Clinic is located at 4F, 71 Dokseodang-ro, Yongsan-gu, Seoul, Republic of Korea, and is a Registered Medical Institution for Attracting Foreign Patients, certified by the Korean Ministry of Health and Welfare. An English-speaking coordinator supports inquiries and interprets during consultations to help international patients communicate clearly with the clinical team.
This article was medically reviewed by Dr. Heejun Kim, the clinic's Chief Director and a board-certified orthopedic surgeon (a Korean credential). His background includes training at Yonsei University College of Medicine and an orthopedic surgery residency at Severance Hospital, along with roles as a Clinical Instructor and a Clinical Professorship at the Artificial Joint Center at Severance. He is a regular member of multiple Korean and international societies, including the International Society for Medical Shockwave Treatment (ISMST).
Frequently Asked Questions
Is ESWT approved by the FDA?
Yes, but only for specific conditions. In the United States, ESWT is FDA-approved for chronic proximal plantar fasciitis (2000) and chronic lateral epicondylitis, or tennis elbow (2003), in adults who have failed conservative treatment for at least six months. Most other musculoskeletal uses are considered off-label, and care at Nucellin Orthopedic Clinic is delivered under Korean medical regulation.
What is the difference between focused and radial shockwaves?
Focused shockwaves concentrate energy at a specific depth, so they can reach and precisely target deeper structures such as a tendon insertion. Radial pressure waves are strongest at the surface and spread outward, making them suited to broader, more superficial areas. Neither is universally better; a dual-mode device such as the STORZ Ultra SD1 lets the physician match the mode to the diagnosis.
Does ESWT hurt, and is it invasive?
ESWT is non-invasive, with no incisions and no injection. During treatment, most patients feel a tapping or pulsing sensation and some discomfort at the site, and the intensity can usually be adjusted. Temporary soreness, redness, or mild bruising afterward is common and typically settles quickly.
How many sessions will I need?
There is no universal answer. A course usually involves several sessions spaced over a few weeks, but the exact number, the energy settings, and the intervals are individualized based on your diagnosis and response. Be cautious of any source that promises a fixed formula or a guaranteed result.
How soon will I feel better after ESWT?
Improvement is often gradual rather than immediate, with many patients noticing change over the weeks following a course. Some people respond well, and others do not respond as hoped, which is why honest expectations matter. ESWT aims to reduce pain and support function in appropriately selected patients, with results that vary.
Is ESWT a cure for plantar fasciitis or tendon pain?
No. ESWT is not a cure and does not guarantee permanent, pain-free results. It is one non-invasive option that may help selected patients as part of a broader plan that includes correct diagnosis, exercise, and conservative measures. Whether it is appropriate for you is decided by examination.
The Bottom Line
- ESWT delivers acoustic pressure waves through the skin to stimulate the body's own response in painful tendon and heel tissue; it is non-invasive and given as a course of sessions.
- In the United States, ESWT is FDA-approved only for chronic plantar fasciitis (2000) and chronic lateral epicondylitis (2003) after failed conservative care; other musculoskeletal uses are off-label.
- Focused and radial shockwaves are physically different; the STORZ MEDICAL Ultra SD1 offers both so treatment can be matched to the depth and type of the problem.
- Recovery is typically simple, with temporary local soreness; improvement is often gradual, and individual results vary with no guarantees.
- Care at Nucellin Orthopedic Clinic is delivered under Korean medical regulation; candidacy is decided by examination and imaging, with a conservative-first approach.
Disclaimer
This article is for general educational purposes only and is not a self-diagnosis tool. It does not replace an in-person consultation, examination, or personalized advice from a qualified physician. In the United States, ESWT is FDA-approved only for chronic plantar fasciitis and chronic lateral epicondylitis after failed conservative care, and other uses are off-label; care at Nucellin Orthopedic Clinic is delivered in the Republic of Korea under Korean medical regulation, not under U.S. regulation. No specific result is guaranteed, and individual outcomes vary. Always seek the advice of a qualified health provider with any questions about a medical condition.
More Articles
Continue reading our clinical guides.